Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • Lifestyle & Wellbeing

New insights warn that evening drinks can disrupt overnight blood sugar and sleep quality

Nutrition experts highlight the impact of evening beverages rich in sugar and caffeine on blood glucose levels and sleep, advocating for safer options like water and unsweetened tea to support long-term health. Nutrition experts are warning that what people drink…

  • apxadmin
  • September 29, 2026
  • Diet & Nutrition

Blue Shield of California invests in food as medicine to expand healthcare access

Blue Shield of California commits $300,000 to expand its ‘Food as Health’ initiative, aiming to link nutrition directly with healthcare for Medicaid patients managing chronic conditions across the state. Blue Shield of California has launched a statewide “Food as Health”…

  • apxadmin
  • September 29, 2026
  • Diet & Nutrition

Thirty years on, psychosocial care remains central to diabetes research and management

Celebrating three decades of the PsychoSocial Aspects of Diabetes Study Group, a special issue of Diabetic Medicine underscores the ongoing importance of psychosocial factors in diabetes care, highlighting advances and future priorities in understanding emotional and social challenges faced by…

  • apxadmin
  • September 29, 2026
  • Glycaemic Index

New study finds no link between semaglutide and pancreatic cancer risk

Research presented at the European Association for the Study of Diabetes meeting provides reassuring evidence that semaglutide does not increase pancreatic cancer risk, addressing longstanding safety concerns around the drug class. New research presented at the European Association for the…

  • apxadmin
  • September 29, 2026
  • Glycaemic Index

Study on GIP and semaglutide highlights differences from tirzepatide's dual pathway action

A recent study examining GIP infusion with semaglutide underscores that short-term physiological experiments do not provide conclusive evidence about tirzepatide’s long-term efficacy, highlighting the importance of understanding drug mechanisms and study limitations. A recent discussion about tirzepatide has highlighted a…

  • apxadmin
  • September 29, 2026
  • Diet & Nutrition

Engineered stem cells show promise in reversing type 1 diabetes in mice by reprogramming immune response

Researchers at the Medical University of South Carolina have demonstrated that a single infusion of engineered mesenchymal stem cells can reverse new-onset type 1 diabetes in female mice by modulating immune cells, sparking hope for cell-based treatments aiming to restore…

  • apxadmin
  • September 29, 2026
  • Diet & Nutrition

Small link found between GLP-1 diabetes drugs and rare eye disorder with potential for vision loss

Rutgers University researchers have identified a modest association between GLP-1 receptor agonists, commonly used for diabetes and obesity, and a rare eye condition that can cause sudden vision loss, prompting further investigation into these widely prescribed medications. Rutgers University researchers…

  • apxadmin
  • September 29, 2026
  • Glycaemic Index

Choosing the right bread and fillings can improve blood sugar control, experts say

Dietitians emphasise the importance of selecting wholegrain bread and balanced fillings for morning sandwiches to better manage blood sugar levels, according to health experts and recent research. A morning sandwich may seem harmless, but nutrition guidance suggests that the type…

  • apxadmin
  • September 28, 2026
  • Diet & Nutrition

Novo Nordisk's CagriSema outperforms tirzepatide in weight loss trial for type 2 diabetes

In a late-stage trial, Novo Nordisk’s experimental drug CagriSema achieved greater weight reduction than tirzepatide at the 5 mg dose, signalling a potential breakthrough in diabetes and weight management treatments. Novo Nordisk said its experimental obesity drug CagriSema produced greater…

  • apxadmin
  • September 28, 2026
  • Glycaemic Index

New strategies help GLP-1 users manage digestive side effects effectively

Patients using GLP-1 medicines for type 2 diabetes are turning to innovative food and hydration solutions to counteract common digestive side effects, improving treatment success and quality of life. GLP-1 medicines have become a mainstay in type 2 diabetes care,…

  • apxadmin
  • September 28, 2026
Prev
1 … 63 64 65 66 67 68 69 … 200
Next

Search

No results

Posts

High blood sugar despite metformin: a need for re-evaluation and stronger treatment, says expert

September 11, 2026

Unwalkable neighbourhoods linked to higher LDL risk among Black adults with type 2 diabetes

October 17, 2026

Choosing the right bread and fillings can improve blood sugar control, experts say

September 28, 2026

Telehealth boosts confidence and engagement in rural Mississippi diabetes care

August 26, 2026

Oklahoma woman transforms life after losing 143kg through diet, medication, and bariatric surgery

September 15, 2026

Trending now

Bamboo extract dampens diabetes-linked cell stress in rats, study finds
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy